Compounded Tirzepatide: The Most Effective Weight Loss Medication Available
Quick Answer
Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GLP-1/GIP receptor agonist that produced 20.9% average body weight loss in clinical trials — the most effective approved weight loss medication to date. Compounded tirzepatide at Marrow starts at $339/month.
Tirzepatide represents a significant leap forward in metabolic medicine. Unlike single-mechanism GLP-1 drugs such as semaglutide, tirzepatide activates two incretin hormone receptors simultaneously — GLP-1 and GIP — producing superior weight loss and metabolic improvements in head-to-head comparisons. Originally developed by Eli Lilly and approved as Mounjaro (for diabetes) and Zepbound (for weight management), compounded tirzepatide offers the same active ingredient through FDA-registered pharmacies at a dramatically lower cost.
What makes tirzepatide different
Most GLP-1 medications activate a single receptor. Tirzepatide is a “twincretin” — it simultaneously activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. This dual mechanism produces effects that neither pathway achieves alone: greater appetite reduction, improved insulin sensitivity, better glucose control, and superior body composition changes.
The GIP component is particularly interesting for body composition. GIP receptors are expressed in adipose tissue, and their activation appears to improve how the body handles fat metabolism — potentially explaining why tirzepatide produces greater fat loss relative to lean mass loss compared to GLP-1-only medications.
The SURMOUNT trial results
The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, was the landmark study that established tirzepatide as the most effective weight loss medication available. Key results at 72 weeks:
Tirzepatide 5mg
15.0%
avg body weight loss
Tirzepatide 10mg
19.5%
avg body weight loss
Tirzepatide 15mg
20.9%
avg body weight loss
For context, the placebo group lost 3.1%. At the highest dose, participants lost an average of approximately 52 pounds. More than a third of participants on the 15mg dose lost over 25% of their body weight — results previously only seen with bariatric surgery.
GLP-1 vs GLP-1/GIP mechanism
Semaglutide (Ozempic/Wegovy) activates one receptor: GLP-1. Tirzepatide activates two: GLP-1 and GIP. While both reduce appetite and improve blood sugar, the dual mechanism produces additional metabolic benefits. GIP activation appears to enhance fat oxidation, improve lipid metabolism, and provide a buffering effect on GI side effects — which may explain why some patients tolerate tirzepatide better than semaglutide.
Semaglutide vs tirzepatide comparison
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 only | GLP-1 + GIP (dual) |
| Avg weight loss | ~15% | ~21% |
| Brand names | Ozempic, Wegovy | Mounjaro, Zepbound |
| Marrow price | $249/mo | $339/mo |
| Best for | First-time GLP-1, budget | Max results, plateaus |
Safety
Tirzepatide shares a similar safety profile with other GLP-1 medications. The most common side effects — nausea, diarrhea, constipation — are manageable through slow dose titration and typically resolve within a few weeks. At Marrow, your physician starts you at the lowest dose and increases gradually, monitoring for tolerability at each step.
Pricing
Compounded tirzepatide at Marrow starts at $339/month. Brand-name Mounjaro/Zepbound typically costs $1,000-1,300/month without insurance. That's a potential savings of $11,532 per year. Every plan includes physician oversight, all supplies, and free shipping.
View full pricing details or compare weight loss treatment options.
How to start
Complete your intake
A quick 5-minute questionnaire about your health, goals, and medical history.
Physician review
A licensed physician reviews your intake within 24 hours and discusses whether tirzepatide is right for you.
Prescription ships
Your tirzepatide is compounded by an FDA-registered pharmacy and shipped to your door in 3-5 days.
Frequently asked questions
Tirzepatide vs semaglutide — which is better?
Tirzepatide produced greater average weight loss in clinical trials (20.9% vs 15% body weight). However, individual results vary significantly. Semaglutide has a longer track record, more safety data, and is more affordable. Many patients start with semaglutide and switch to tirzepatide if they plateau. Your Marrow physician will help determine which is best for your specific situation.
Is 20% weight loss realistic?
The SURMOUNT-1 trial showed an average of 20.9% body weight loss at the highest dose (15mg) over 72 weeks. Some patients lost more, some less. Individual results depend on starting weight, diet, exercise, genetics, and adherence. At Marrow, your physician sets realistic expectations based on your specific profile.
What is Mounjaro vs Zepbound?
Both contain tirzepatide. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is FDA-approved specifically for weight management. The active ingredient is identical — the difference is the approved indication and labeling. Compounded tirzepatide at Marrow uses the same active pharmaceutical ingredient.
How long until I see results?
Most patients notice reduced appetite within 1-2 weeks. Measurable weight loss typically begins within 4-8 weeks. The full effects of tirzepatide develop over 6-12 months as the dose is gradually increased. Patience and consistency are key.
What are the side effects?
The most common side effects are nausea, diarrhea, and constipation, particularly during dose increases. These typically resolve within 2-4 weeks. Tirzepatide may cause fewer GI side effects than semaglutide in some patients due to its dual mechanism. Your Marrow physician manages side effects through careful dose titration.
Is compounded tirzepatide safe?
Yes. Compounded tirzepatide uses the same active pharmaceutical ingredient as Mounjaro and Zepbound. It's prepared by FDA-registered 503B compounding pharmacies under strict quality controls, with every batch tested for potency and purity.
Can I switch from semaglutide to tirzepatide?
Yes. Many patients start with semaglutide and switch to tirzepatide if they plateau or want to try the dual-mechanism approach. Your Marrow physician will manage the transition safely, typically with a washout period and gradual re-titration.
Start tirzepatide for $339/mo
The most effective weight loss medication available. Physician review within 24 hours.
Start your intake →